Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) — Strategic Asset Allocation Index
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Strategic Asset Allocation Index of 44.3% as of September 2023. Strategic assets (PP&E of CN¥1.03 Billion plus long-term investments of CN¥-) total CN¥1.03 Billion, measured against net assets of CN¥2.32 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Tonghua Golden-Horse Pharmaceutical Indu asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of September 2023, the index stands at 44.3%, representing strategic assets of CN¥1.03 Billion against net assets of CN¥2.32 Billion CNY. See Tonghua Golden-Horse Pharmaceutical Indu leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Tonghua Golden-Horse Pharmaceutical Indu (000766) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44.4% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥2.37 Billion | ▼ -2.0 pp |
| 2021 | 46.5% | CN¥1.09 Billion | CN¥1.09 Billion | CN¥- | CN¥2.34 Billion | ▲ +2.9 pp |
| 2020 | 43.6% | CN¥1.00 Billion | CN¥1.00 Billion | CN¥- | CN¥2.31 Billion | ▲ +5.0 pp |
| 2019 | 38.5% | CN¥1.03 Billion | CN¥1.03 Billion | CN¥- | CN¥2.67 Billion | ▲ +16.3 pp |
| 2018 | 22.2% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥4.71 Billion | ▼ -0.8 pp |
| 2017 | 23.0% | CN¥1.02 Billion | CN¥1.02 Billion | CN¥- | CN¥4.42 Billion | ▲ +0.2 pp |
| 2016 | 22.8% | CN¥948.40 Million | CN¥948.40 Million | CN¥- | CN¥4.16 Billion | ▼ -9.3 pp |
| 2015 | 32.1% | CN¥721.52 Million | CN¥721.52 Million | CN¥- | CN¥2.25 Billion | ▼ -33.4 pp |
| 2014 | 65.5% | CN¥431.86 Million | CN¥431.86 Million | CN¥- | CN¥659.50 Million | ▲ +18.6 pp |
| 2013 | 46.9% | CN¥288.55 Million | CN¥288.55 Million | CN¥- | CN¥615.08 Million | ▲ +26.4 pp |
| 2012 | 20.5% | CN¥126.92 Million | CN¥126.92 Million | CN¥- | CN¥619.60 Million | ▼ 0.0 pp |
| 2011 | 20.5% | CN¥124.48 Million | CN¥124.48 Million | CN¥- | CN¥607.13 Million | ▼ -26.6 pp |
| 2010 | 47.1% | CN¥280.61 Million | CN¥280.61 Million | CN¥- | CN¥595.89 Million | ▼ -3.3 pp |
| 2009 | 50.4% | CN¥294.39 Million | CN¥294.39 Million | CN¥- | CN¥583.87 Million | ▼ -3.2 pp |
| 2008 | 53.7% | CN¥297.30 Million | CN¥297.30 Million | CN¥- | CN¥554.08 Million | ▼ -3.0 pp |
| 2007 | 56.6% | CN¥303.95 Million | CN¥303.95 Million | CN¥- | CN¥536.90 Million | ▲ +24.9 pp |
| 2006 | 31.7% | CN¥164.08 Million | CN¥164.08 Million | CN¥- | CN¥518.07 Million | ▼ -377.3 pp |
| 2005 | 408.9% | CN¥185.08 Million | CN¥185.08 Million | CN¥- | CN¥45.26 Million | ▲ +8.2 pp |
| 2004 | 400.8% | CN¥146.83 Million | CN¥146.83 Million | CN¥- | CN¥36.64 Million | ▲ +315.2 pp |
| 2003 | 85.6% | CN¥253.29 Million | CN¥253.29 Million | CN¥- | CN¥296.07 Million | ▲ +48.7 pp |
| 2002 | 36.8% | CN¥180.70 Million | CN¥180.70 Million | CN¥- | CN¥490.79 Million | ▼ -0.8 pp |
| 2001 | 37.6% | CN¥178.56 Million | CN¥178.56 Million | CN¥- | CN¥475.05 Million | ▲ +16.7 pp |
| 2000 | 20.9% | CN¥225.41 Million | CN¥225.41 Million | CN¥- | CN¥1.08 Billion | — |